期刊文献+

滤蓝光变色人工晶体对兔视网膜光损伤保护作用的实验研究 被引量:2

Experimental study on the protective effect of a blue light-filtering intraocular lens from retinal injury
下载PDF
导出
摘要 目的探讨短波长蓝光对兔视网膜造成损伤的可能机制及滤蓝光变色人工晶体对兔视网膜色素上皮细胞的保护功能。方法将健康新西兰兔26只随机分为两组,分别在行晶体摘除术后植入滤蓝光变色人工晶体和普通紫外线阻断型人工晶体,后用UVR光源(350-450nm)每天照射实验兔眼8h,3个月后取视网膜组织制成冰冻切片后行免疫组化法检测血管生长因子(VEGF)的表达,TUNEL法检测黄斑区视网膜色素上皮层细胞(RPE细胞)凋亡情况。结果 UVR照射后滤蓝光变色人工晶体较普通紫外线阻断型人工晶体黄斑区视网膜RPE细胞出现凋亡改变减少,免疫组化法检测植入普通紫外线阻断型人工晶体组VEGF的表达升高(P<0.05)。结论短波长蓝光能导致兔视网膜RPE细胞凋亡,功能障碍,同时刺激VEGF表达增多,导致眼底视网膜病变。滤蓝光变色人工晶体能有效阻断紫外蓝光,对视网膜细胞有保护作用。 Objective To explore the blue light-filtering intraocular lens (IOLs) protection on retinal pigment epithelium(RPE). Methods 26 healthy rabbits with phacoemulsification were randomly divided into two groups,Half were implanted the blue light-filtering IOLs,the other half were implanted the ultraviolet (UV) blocking IOLs,with ultraviolet light (UVR) daily irradiation experi-ments in rabbit eyes 8 hours a day. After 3 months retinal tissue biopsy were carried out by H-E staining ,retinal tissue frozen sections underwent immunohistochemical to evaluate expression of vascular endothelial growth factor (VEGF)assay ,apoptosis by TUNEL of macular retinal conditions. Results After UVR irradiation increased retinal RPE cells apoptosis were found in the rab-bits with the ultraviolet (UV) blocking IOLs,more than the rabbits with blue light-filtering IOLs. Immunohistochemical assay ele-vated VEGF expression obviously increased in ultraviolet blocking IOLs group compare to the blue light-filtering IOLs group. (P〈0.05). Conclusion The blue light-filtering IOLs has a protective effect on retinal cells for it can block the blue light inducing apoptosis of retinal RPE cells,sitimulating VEGF expression and causing dysfunction of retinal.
出处 《江西医药》 CAS 2014年第11期1168-1171,共4页 Jiangxi Medical Journal
关键词 滤蓝光变色人工晶体 血管内皮生长因子 黄斑变性 凋亡 The blue light-filtering IOLs Vascular endothelial growth factor(VEGF) Macular degeneration apoptosis
  • 相关文献

参考文献12

  • 1Pons A,Delgado D,Campos J,et al. Determination of the action spectrum of the blue-light hazard for different intraocular lenses [J]. OptSoc AmAOpt Image Sci Vis,2007,24:1545.
  • 2Schwiegerling J. Blue-light-absorbing lenses and their effect on scatopic vision[J]. Cataract Refract Surg,2006,32:141.
  • 3Mester U,Holz F,Kohnen T,et al. Intraindividual comparison of a blue-light filter on visual function:AF-1 (UY) versus AF-1 (UV)intraocular lens[J]. Cataract Refract Surg,2008,34:608.
  • 4Mainster MA,Turner PL. Photic retinal injury and safety [J]. St Louis : Mosby, 2001,1 : 797.
  • 5Beatty S, Boulton M, Hensn D, et al. Macular pigment and age re- latedmacular degeneration[J]. Br Ophthalmol, 1999,83 : 867.
  • 6Nozaki M, Raisler B J, Sakurai E,et al. Drusen complement compo- nents C3a and C5a promote choroidal neovascularization [J]. Proc Natl Acad Sci USA,2006,103:2328.
  • 7Algvere PV, Marshall J, Seregard S, et al. Age-related maculopathy and the impact of blue light hazard [J]. Acta Ophthalmol Stand, 2006,84:4.
  • 8Muftuoglu O,Karel F,Duman R,et al. Effect of a yellow intraocular lens on scotopic vision,glare disability,and blue color perception [J]. Cataract Refract Surg,2007,33:658.
  • 9Mainster MA,Sparrow JR. How much blue light should an IOL transmit[J]. Br Ophthalmo1,2003,87 : 1523.
  • 10Algvere PV, Marshall J, Seregard S, et al. Age-related maculopa- thy and the impact of blue light hazard [J]. Acta Ophthalmol Scand, 2006,84: 4.

二级参考文献14

  • 1岑洪译.抗肿瘤新药:首个VEGF抑制剂Bevacizumab上市[J].广西医学,2005,27(4):608-611. 被引量:10
  • 2Kvanta A,Alg'vere Pv,Berglin L,et al.Subfoveal fibrova Aarmen branes in age related maeular degeneration express vascular en. dothehal growth actor.Invest Ophthalmol vis Sci, 1996,37:1929.
  • 3Krzystolik MG,M shari MA,Adfmis P,et al.Prevention of experimental ehomidal neovascularization with intravitreal anti--vascular endothelial growth factor antibody fragment.Arch Ophthalmol,2002, 120:338.
  • 4Carmeliet P.Mechanisms of angiogenesis and arteriogenesis.NatMcd, 2000,6:389.
  • 5Errara N.Vascular endothelial growth factor:molecular and biologieal aspects.CUlT Top Microbiol Immanol, 1999,237:30.
  • 6GordonM S,M argolinK ,Ta lpazM ,et al.P hase Is afetya ndp harmacokinetic study of recombinat human anti-vascular endothelial growth factor in patients with advanced cancer.J Clin Oncol,20011,19(4);843.
  • 7Shahar J,Avery RL,Heilweil G,et al.EIectr0physigic and etinalpenetration studies following intravitreal injection of bevacizumab(Avastin) Retina, 2006,26(3): 262.
  • 8Pradeepa yoganathan, md,*Vincent a.deramo, md,* James c. lai, md, *Rajen k.tibrewala, desc,david m. fastenberg, md* retina 200,26: 994.
  • 9Rodrigo jorge, rod, phd, intravitreal bevacizumab (avastin) for persistent new essels in diabetic retinopathy,retina,the journal of retinal and vitreous diseases 2006 volume 26 number 9.
  • 10Melvin d.rabena,bs,dante j.pieramici,md,intravitreal bevacizumab (avastin) in the treatment of macular edema secondary to branch retinal vein occlusion,retina 2007 27:419.

同被引文献18

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部